News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,370 Results
Type
Article (87786)
Company Profile (824)
Press Release (778744)
Multimedia
Podcasts (188)
Webinars (28)
Section
Business (233177)
Career Advice (4144)
Deals (39843)
Drug Delivery (144)
Drug Development (91368)
Employer Resources (203)
FDA (18362)
Job Trends (17415)
News (397736)
Policy (39951)
Tag
Academia (3006)
Academic (2)
Accelerated approval (28)
Adcomms (35)
Allergies (136)
Alliances (56981)
ALS (171)
Alzheimer's disease (1763)
Antibody-drug conjugate (ADC) (311)
Approvals (18488)
Artificial intelligence (583)
Autoimmune disease (136)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (191)
Biotechnology (488)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (628)
Cancer (4738)
Cardiovascular disease (413)
Career advice (3566)
Career pathing (40)
CAR-T (292)
CDC (59)
Celiac Disease (1)
Cell therapy (790)
Cervical cancer (37)
Clinical research (76625)
Collaboration (1625)
Company closure (5)
Compensation (1081)
Complete response letters (65)
COVID-19 (2980)
CRISPR (93)
C-suite (751)
Cystic fibrosis (148)
Data (5901)
Decentralized trials (2)
Denatured (69)
Depression (133)
Diabetes (501)
Diagnostics (7177)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (278)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (227)
Earnings (99902)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134579)
Executive appointments (1011)
FDA (21263)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1453)
Gene editing (203)
Generative AI (60)
Gene therapy (630)
GLP-1 (1089)
Government (5421)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (278)
Immuno-oncology (42)
Indications (78)
Infectious disease (3255)
Inflammatory bowel disease (198)
Inflation Reduction Act (16)
Influenza (115)
Intellectual property (221)
Interviews (816)
IPO (17944)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10154)
Liver cancer (95)
Longevity (14)
Lung cancer (651)
Lymphoma (361)
Machine learning (40)
Management (66)
Manufacturing (756)
MASH (168)
Medical device (14976)
Medtech (15016)
Mergers & acquisitions (22886)
Metabolic disorders (1308)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (325)
Neuropsychiatric disorders (87)
Neuroscience (2973)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (627)
Opinion (327)
Ovarian cancer (153)
Pain (193)
Pancreatic cancer (206)
Parkinson's disease (275)
Partnered (36)
Patents (473)
Patient recruitment (420)
Peanut (59)
People (66660)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23663)
Phase II (33253)
Phase III (25071)
Pipeline (4003)
Policy (319)
Postmarket research (3554)
Preclinical (10669)
Press Release (72)
Prostate cancer (231)
Psychedelics (53)
Radiopharmaceuticals (291)
Rare diseases (819)
Real estate (7436)
Recruiting (80)
Regulatory (28623)
Reports (65)
Research institute (2718)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (149)
Series A (244)
Series B (178)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (97)
The Weekly (117)
Vaccines (1111)
Venture capital (82)
Weight loss (437)
Women's health (79)
Worklife (21)
Date
Today (15)
Last 7 days (586)
Last 30 days (2327)
Last 365 days (33170)
2025 (32909)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (328)
Arkansas (14)
Asia (51352)
Australia (9020)
California (10890)
Canada (3184)
China (1071)
Colorado (459)
Connecticut (481)
Delaware (329)
Europe (118027)
Florida (1595)
Georgia (353)
Hawaii (3)
Idaho (68)
Illinois (904)
India (62)
Indiana (525)
Iowa (22)
Japan (388)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1401)
Massachusetts (8060)
Michigan (344)
Minnesota (633)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (27)
Nevada (118)
New Hampshire (81)
New Jersey (2963)
New Mexico (32)
New York (2908)
North Carolina (1541)
North Dakota (10)
Northern California (5141)
Ohio (332)
Oklahoma (22)
Oregon (52)
Pennsylvania (2207)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (61)
South Dakota (1)
Southern California (4183)
Tennessee (168)
Texas (1716)
United States (39599)
Utah (325)
Vermont (1)
Virginia (274)
Washington D.C. (85)
Washington State (921)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
There are 867,370 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tolmar Announces Expanded Indication for Rubraca® (rucaparib) First and Only PARP Inhibitor to Outperform Docetaxel in a Head-to-Head Phase 3 Trial
December 22, 2025
·
10 min read
Press Releases
Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China
December 22, 2025
·
6 min read
Press Releases
European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor
December 22, 2025
·
14 min read
Press Releases
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
December 22, 2025
·
8 min read
Press Releases
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
December 22, 2025
·
23 min read
Press Releases
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
December 22, 2025
·
6 min read
Press Releases
Cue Biopharma Announces Pricing of $10 Million Public Offering
December 22, 2025
·
5 min read
Press Releases
Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027
December 22, 2025
·
6 min read
Press Releases
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
December 22, 2025
·
3 min read
Press Releases
Outlook Therapeutics Reports Financial Results for Fiscal Year 2025
December 22, 2025
·
8 min read
1 of 86,737
Next
